Revenue
$269.4m
-46.3% ↓ vs $501.4m
Underwriting rebounded sharply and the interim dividend resumed at 3.0 cps, but the revenue line is broken by an insurance-presentation basis change.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY24 vs HY23
Revenue
$269.4m
-46.3% ↓ vs $501.4m
Net profit after tax
$36m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$35.3m
+94.6% ↑ vs $18.2m
Interim dividend per share
3.0c
— vs —
Profit before tax
$47.8m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$79.4m
-17.8% ↓ vs $96.6m
Total assets
$615m
-42.1% ↓ vs $1.1b
What changed
Management's underlying NPAT was NZ$36.6m, only fractionally above reported, so the headline is essentially clean of non-recurring adjustments. PBT margin came in at 17.7%, at the upper edge of Annolyse's historical range (4-period mean 8.4%), and NPAT margin at 13.4% (mean 5.7%) sits in similar territory.
The revenue line, however, is not a clean comparison. The current period shows "Insurance revenue" of NZ$269.4m against a prior reported revenue of NZ$501.4m, and the canonical revenue-growth figure has been suppressed for basis discontinuity. Investment income rose to NZ$10.0m (HY23 NZ$6.4m). Operating cash flow lifted to NZ$35.3m (HY23 NZ$18.2m), and an interim dividend of 3.0 cps was declared after no dividend in HY23 or FY23.
What matters
Excerpts attribute the turnaround to targeted rate increases, improved processes, lower motor theft claims following underwriting action, and calmer weather. The result is consistent with this: PBT margin at the top of the historical range coincides with the absence of the large-event reinsurance reinstatement costs that dragged HY23. This matters because the rebound is concentrated in the loss-experience line, which is structurally volatile in NZ general insurance.
Capital signalling has shifted. The resumed 3.0 cps interim dividend, against a backdrop where FY23 paid nothing, indicates management has rebuilt enough headroom to distribute. Total equity rose to NZ$333.7m from NZ$295.6m, while total assets sit at NZ$615.0m, at the lower edge of the historical range (mean NZ$787.7m). The combination of falling assets and rising equity reflects the basis change rather than balance-sheet contraction, but the equity build is real and supports the capital read.
Investment income is a meaningful contributor. At NZ$10.0m (+55.7%), higher cash yields are amplifying the underwriting recovery rather than carrying it. The earnings story should not be read as purely rate-driven; pricing and claims discipline are the larger levers.
Expectations
Annualising current revenue gives NZ$538.9m, but that is mechanical only.
What the release supports is a profitability inflection: PBT and NPAT margins are at the upper edge of the historical range on a basis where the company has previously struggled to hold positive margins through severe-weather seasons. What it does not support is a view on second-half claims experience, which depends on cyclone and storm activity Tower cannot control.
Quality of result
Reported NPAT (NZ$36.0m) and underlying NPAT (NZ$36.6m) are within NZ$0.6m of each other, so the gap between statutory and underlying is unusually small for Tower. The effective tax rate normalised to 32.2% (within Annolyse's historical range), compared to 10.3% in HY23 when a small pre-tax loss distorted the ratio, so the NPAT swing is not flattered by a tax credit.
Cash backing is consistent with reported earnings: free cash flow pre-lease of NZ$33.7m is within the historical range, current FCF-to-NPAT conversion sits at 93.5%, and capex remains light at 0.6% of revenue. Operating working capital is essentially neutral on the supplied data.
The principal quality caveat is durability of claims experience rather than accounting. Underwriting margins this strong have not been the norm in the historical baseline, and the release explicitly credits calmer weather alongside management actions. Some portion of the margin step-up therefore depends on weather not repeating HY23 conditions in the second half.
Unresolved
This briefing cannot assess Tower's regulatory solvency position, reinsurance program economics, or claims-reserve adequacy from the supplied materials.
Chat
Ask follow-up questions about Tower's HY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Interim Financial Statements (including Independent Auditor's Review Report)
HY24 / financial reportMedia Release
HY24 / media releaseResults Announcement
HY24 / results announcementResults Announcement Presentation
HY24 / results presentationTower HY23 Financial Statements (including auditor's report)
HY23 / financial reportTower HY23 Media Release
HY23 / media releaseTower HY23 Results Announcement
HY23 / results announcementTower HY23 Results Announcement Presentation
HY23 / results presentationAnnual Report (including Financial Statements)
FY23 / financial reportResults Announcement
FY23 / results announcementResults Announcement
FY23 / results releaseResults Presentation
FY23 / results presentationTower updates FY23 guidance and large events costs
FY23 / commentaryAnnual Meeting Address
HY23 / commentaryTower Updates Guidance, Provides Update on Large Events
HY23 / commentaryTower Limited Annual Meeting Materials
HY24 / commentaryTower Updates Guidance
HY24 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
This result includes a statutory earnings-quality distortion flag.
Revenue growth context
Revenue growth was -46.3% for this reporting period.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 31.6%.
ROE and capital efficiency
ROE was 10.8%, +12.5pp versus the prior comparable period.
Get the next Tower briefing and related NZX reporting-season updates by email.